CVRx (CVRX) Gains from Investment Securities (2020 - 2021)
CVRx (CVRX) posted quarterly Gains from Investment Securities of -$1.8 million for Q3 2021, down 398.92% year-over-year from $617558.8 in Q3 2020, and down 116.12% quarter-over-quarter from $11.5 million in Q2 2021.
CVRx (CVRX) Gains from Investment Securities (2020 - 2021) Analysis & Trends
CVRx's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$1.8 million for Q3 2021.
- In Q3 2021, Gains from Investment Securities fell 398.92% year-over-year to -$1.8 million; the TTM figure through Jun 2022 stood at -$1.8 million (down 111.89% YoY), while the FY2021 annual figure was $13.3 million, up 3483.29% from the prior year.
- Gains from Investment Securities for Q3 2021 stood at -$1.8 million, down from $11.5 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $11.5 million in Q2 2021, with the low at -$1.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn |
| 10 | CVRx | 75.83 Mn | 11.25 Mn | 13.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.85 Mn |
| Sep 30, 2021 | -1.85 Mn |
| Jun 30, 2021 | 11.45 Mn |
| Jun 30, 2021 | 11.45 Mn |
| Mar 31, 2021 | 3.69 Mn |
| Mar 31, 2021 | 3.69 Mn |
| Dec 31, 2020 | 758,000.00 |
| Dec 31, 2020 | 758,000.00 |
| Sep 30, 2020 | -370,000.00 |
| Sep 30, 2020 | -370,000.00 |